References
- Gestational hypertension and Preeclampsia: aCOG practice bulletin summary, number 222. Obstet Gynecol. 2020;135(6):1492–6. doi:10.1097/AOG.0000000000003892
- Sibai B. Etiology and management of postpartum hypertension-preeclampsia. Am J Obstet Gynecol. 2011;206(6):470–475. doi:10.1016/j.ajog.2011.09.002.
- Stevens W, Shih T, Incerti D, et al. Short-term costs of preeclampsia to the United States health care system. Am J Obstet Gynecol. 2017;217(3):237–248.e16. doi:10.1016/j.ajog.2017.04.032
- Magpie Trial Follow-Up Study Collaborative Group. The Magpie trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for women at 2 years. Br J Obstet Gynaecol. 2007;114(3):300–309. doi:10.1111/j.1471-0528.2006.01166.x
- Stefanovic V. International Academy of Perinatal Medicine (IAPM) guidelines for screening, prediction, prevention and management of pre-eclampsia to reduce maternal mortality in developing countries. J Perinat Med. in press. doi:10.1515/jpm-2021-0636
- Cairns A, Pealing L, Duffy JMN. Postpartum management of hypertensive disorders of pregnancy: a systematic review. BMJ Open. 2017;7(11):1–14. doi:10.1136/bmjopen-2017-018696.
- Webster LM, Myers JE, Nelson-Piercy C, et al. Labetalol versus nifedipine as antihypertensive treatment for chronic hypertension in pregnancy: a randomized controlled trial. Hypertension. 2017;70(5):915–922. doi:10.1161/HYPERTENSIONAHA.117.09972
- Ainuddin J, Javed F, Kazi S. Oral labetalol versus oral nifedipine for the management of postpartum hypertension a randomized control trial. Pak J Med Sci. 2019;35(5):1428–1433. doi:10.12669/pjms.35.5.812.
- Lamminpää R, Vehviläinen-Julkunen K, Gissler M, et al. Preeclampsia complicated by advanced maternal age: a registry-based study on primiparous women in Finland 1997–2008. BMC Pregnancy Childbirth. 2012;12(1):47. doi:10.1186/1471-2393-12-47
- Gyamfi-Bannerman C, Pandita A, Miller EC, et al. Preeclampsia outcomes at delivery and race. J Matern Fetal Neonatal Med. 2020;33(21):3619–3626. doi:10.1080/14767058.2019.1581522
- Shao Y, Qiu J, Huang H, et al. Pre-pregnancy BMI, gestational weight gain and risk of preeclampsia: a birth cohort study in Lanzhou, China. BMC Pregnancy Childbirth. 2017;17(1):400. doi:10.1186/s12884-017-1567-2
- Weissgerber TL, Mudd LM. Preeclampsia and diabetes. Curr Diab Rep. 2015;15(3):9. doi:10.1007/s11892-015-0579-4.
- Lovgren T, Connealy B, Yao R, et al. Postpartum management of hypertension and effect on readmission rates. Am J Obstet Gynecol MFM. 2022;4(1):100517. doi:10.1016/j.ajogmf.2021.100517
- Uitvlugt EB, Janssen MJA, Siegert CEH, et al. Medication-related hospital readmissions within 30 days of discharge: prevalence, preventability, type of medication errors and risk factors. Front Pharmacol. 2021;12:567424. doi: 10.3389/fphar.2021.567424
- Glick K, Rottenstreich M. Management of pregnancy in women of advanced maternal age: improving outcomes for mother and baby. Int J Womens Health. 2021;13:751–759. doi: 10.2147/IJWH.S283216
- Definitive Healthcare. Average hospital readmission rate by state. 2022. [cited Apr 28, 2023]. Available from: https://www.definitivehc.com/resources/healthcare-insights/average-hospital-readmission-state#:~:text=What%20is%20the%20average%20hospital,from%209.9%25%20to%2022.5%25.